Navigation Links
Cephalon Reports Record Earnings and Raises 2010 Guidance
Date:10/28/2010

/p>

-52,563Investment in Ception

-(75,000)Acquisition of Arana, net of cash acquired

-(232,527)Acquisition of Mepha, net of cash acquired

(549,463)-Purchases of investments

(60)(9,292)(Cash settlements of) proceeds from foreign exchange contracts

(9,499)26,754Sales and maturities of available-for-sale investments

-5,074Net cash used for investing activities

(589,263)(276,075)CASH FLOWS FROM FINANCING ACTIVITIES:Proceeds from sale of common stock

-288,000Proceeds from exercises of common stock options

15,1836,701Windfall tax benefits from stock-based compensation

-1,259Acquisition of treasury stock

(33)(29)Acquisition of Ception NCI

(299,289)-Payments on and retirements of long-term debt

(222,079)(11,246)Net proceeds from issuance of convertible subordinated notes

-484,719Proceeds from sale of warrants

-37,640Purchase of convertible note hedge

-(121,040)Net cash (used for) provided by financing activities

(506,218)686,004EFFECT OF EXCHANGE RATE CHANGES ON CASH AND CASH EQUIVALENTS

6,2962,295NET (DECREASE) INCREASE IN CASH AND CASH EQUIVALENTS

(438,645)929,355CASH AND CASH EQUIVALENTS, BEGINNING OF PERIOD

1,647,635524,459CASH AND CASH EQUIVALENTS, END OF PERIOD

$
,208,990$   1,453,814CEPHALON, INC. AND SUBSIDIARIESReconciliation of Projected GAAP Basic Income per Common Shareto Basic Adjusted Income Per Common Share Guidance(Unaudited)Twelve Months EndedTwelve Months EndedDecember 31, 2010December 31, 2011Projected GAAP basic income per common share

$
5.94

$
.14$
.91

$
7.11Amortization of current intangibles

1.57

1.571.41

1.41Accelerated depreciation adjustment- CIMA

0.10

0.100.01

0.01Accelerated depreciation adjustment- Mitry-Mory

0.10


'/>"/>

SOURCE Cephalon, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14

Related biology technology :

1. Drug Sales in the Leukemia Market Will Be Driven By Therapies From Novartis, Bristol-Myers Squibb, Biogen Idec, Roche and Cephalon
2. Cephalon Announces Chairman and CEO to Take Medical Leave of Absence
3. Cephalon Completes Acquisition of Arana Therapeutics
4. Cephalon Appoints Craig C. Phillips as Vice President and General Manager of Oncology Business Unit
5. Cephalon Quarterly Conference Call Invitation
6. Cephalon Prices 5 Million Shares of Common Stock and $435 Million in 2.50% Convertible Senior Subordinated Notes in Public Offerings
7. Cephalon Announces Proposed Public Offering of Common Stock and Convertible Senior Subordinated Notes
8. Cephalons New Product Launches Pace Record 2008 Sales
9. Cephalon Appoints Sarma P. Duddu as General Manager and Vice President of Drug Delivery Technologies for CIMA LABS
10. Cephalon Exercises Option to License Worldwide Rights to ImmuPharma Product, Lupuzor
11. Cephalon and Eurand File Patent Infringement Lawsuit Against Mylan Pharmaceuticals and Barr Pharmaceuticals
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/26/2015)... 2015 S&P Capital IQ (MHFI) announced today ... on MabVax Therapeutics Holdings Inc . ... biotechnology company focused on the development of vaccine and ... treatment of cancer. MabVax has discovered a pipeline of ... responses generated by patients who have been immunized against ...
(Date:2/26/2015)... , Feb. 26, 2015  23andMe, the leading personal ... Black as Privacy Officer and Corporate Counsel. Black ... privacy laws as well as health care regulations. As ... will be responsible for reviewing, updating and enhancing the ... U.S. and abroad. She joined the company January 5, ...
(Date:2/26/2015)... Synageva BioPharma Corp. (NASDAQ: GEVA ... rare disorders, today reported 2014 full year financial ... and financial guidance.  Synageva,s management team will host ... to review the financial results and provide a ... by telephone, please dial (877) 445-4603 for U.S. ...
(Date:2/26/2015)... Protiviti ( www.protiviti.com ), a global consulting ... Governance Portal , designed to increase the efficiency with ... across multiple business units and projects. The Governance Portal ... align their controls with the COSO ( Committee of ... response to client feedback, Protiviti has also included a ...
Breaking Biology Technology:S&P Capital IQ Initiates Coverage on MabVax Therapeutics Holdings Inc. in S&P Capital IQ Factual Stock Reports 2S&P Capital IQ Initiates Coverage on MabVax Therapeutics Holdings Inc. in S&P Capital IQ Factual Stock Reports 3S&P Capital IQ Initiates Coverage on MabVax Therapeutics Holdings Inc. in S&P Capital IQ Factual Stock Reports 4S&P Capital IQ Initiates Coverage on MabVax Therapeutics Holdings Inc. in S&P Capital IQ Factual Stock Reports 523andMe Appoints Kate Black as Privacy Officer and Corporate Counsel 2Synageva BioPharma Reports 2014 Full Year Financial Results 2Synageva BioPharma Reports 2014 Full Year Financial Results 3Synageva BioPharma Reports 2014 Full Year Financial Results 4Synageva BioPharma Reports 2014 Full Year Financial Results 5Synageva BioPharma Reports 2014 Full Year Financial Results 6Synageva BioPharma Reports 2014 Full Year Financial Results 7Synageva BioPharma Reports 2014 Full Year Financial Results 8Synageva BioPharma Reports 2014 Full Year Financial Results 9Protiviti Governance Portal Helps Companies Drive Governance, Risk and Compliance Productivity Across Multiple Business Units 2Protiviti Governance Portal Helps Companies Drive Governance, Risk and Compliance Productivity Across Multiple Business Units 3
... 23 Summary: At Genmab A/S,Annual General Meeting held ... was approved, discharge was given to the Board of ... forward. Two members of the,Board of Directors were re-elected ... proposals from the Board of,Directors to change the Articles ...
... Calif., April 23 STAAR Surgical,Company (Nasdaq: ... of,minimally invasive ophthalmic products, today announced very strong,participation ... on the Company,s,Visian ICL(TM) (Implantable Collamer Lens). The ... "How My Website Compels Patients to Call,Me," is ...
... April 23 Two,leading companies in the ... a new commercial alliance. IOTA Pharmaceuticals Ltd, ... in Uppsala, Sweden, will join forces,to deploy ... The IOTA-Beactica platform couples comprehensive, site-directed ...
Cached Biology Technology:Passing of Genmab A/S' Annual General Meeting 2Passing of Genmab A/S' Annual General Meeting 3Passing of Genmab A/S' Annual General Meeting 4More Than 700 Physicians and Administrators Participate in the Visian ICL Growth Program(TM) Launch 2More Than 700 Physicians and Administrators Participate in the Visian ICL Growth Program(TM) Launch 3New Fragment-based Drug Discovery Platform Announced Between IOTA Pharmaceuticals Ltd, Cambridge (UK), and Beactica AB, Uppsala (Sweden) 2
(Date:2/12/2015)... NXT-ID, Inc. (NASDAQ: NXTD ... company focused on the growing mobile commerce market, announced ... DISTRIBUTED METHOD AND SYSTEM TO IMPROVE COLLABORATIVE ... establishes NXT-ID,s position in the emerging "Internet of Things" ... for multiple devices to collaborate with one another to ...
(Date:2/9/2015)... Texas , Feb. 9, 2015  Lintec of ... fabrication methods for carbon nanotube (CNT) macrostructures, including sheets, ... at Dallas (UTD). Leveraging the vast industrial ... Tokyo, Japan , Lintec of America is ... Richardson, TX , focusing on scaling up ...
(Date:2/5/2015)... , Jan. 26, 2015   Epic Sciences , ... cancer, today announced that Murali Prahalad , Ph.D., president ... Medicine World Conference (PMWC) 2015: Silicon Valley, which is ... Mountain View, Calif. on January 26-28, 2015. ... Come of Age as Biomarkers." Last year, Epic Sciences was ...
Breaking Biology News(10 mins):NXT-ID Patents Collaborative Services to Enable the "Internet of Things" 2NXT-ID Patents Collaborative Services to Enable the "Internet of Things" 3Lintec announces exclusive license to commercialize innovative carbon nanotube technology from the University of Texas at Dallas 2Lintec announces exclusive license to commercialize innovative carbon nanotube technology from the University of Texas at Dallas 3Lintec announces exclusive license to commercialize innovative carbon nanotube technology from the University of Texas at Dallas 4Epic Sciences to Present at Personalized Medicine World Conference 2015 on the Use of Circulating Tumor Cells as Cancer Biomarkers 2
... Ore. For several years, the pharmaceutical industry has ... receptor in the brain, the NMDA receptor. This receptor ... brain and is involved in learning and memory. NMDA ... psychiatric conditions such as Alzheimer,s disease, Parkinson,s disease, schizophrenia ...
... J. Carver Charitable Trust has awarded a $2 million ... University of Illinois at Urbana-Champaign. Under the leadership of ... Christopher Rao, the grant will be disbursed over two ... new research theme devoted to the new scientific subdiscipline ...
... Journal of Animal Science suggests producers may ... grains with solubles (DDGS). Some producers believe that feeding ... DDGS. Firmer fat means longer-lasting pork. But researchers ... fats in DDGS diets makes no difference in fat ...
Cached Biology News:OHSU scientists advance understanding of brain receptor; may help fight neurological disorders 2Roy J. Carver Charitable Trust funds new research focus at Institute for Genomic Biology 2Saturated fats do not yield better bacon 2
...
Caliper offers a wide array of standard LabChip products designed to be used in combination with our AMS 90 and LabChip 3000 microfluidic platforms....
...
... with carbonyl diimidazole chemistry that covalently binds ... array contains the same binding chemistry as ... updated hydrophobic barrier coating. These arrays are ... spots spatially compatible with one column of ...
Biology Products: